| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/20/2002 | CA2250263C Human netrin-1 |
| 08/20/2002 | CA2240138C Quinazolin-4-one ampa antagonists |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2058144C Process for the production of threo-4-alkoxy-5-(arylhydroxymethyl)-2(5h)-furanones |
| 08/20/2002 | CA2052041C Benzimidazole derivatives, their preparation and use |
| 08/20/2002 | CA2045077C Anti-epileptics |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063007A2 TIMM8b-RELATED PROTEIN |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002063005A2 Lipid-associated molecules |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |
| 08/15/2002 | WO2002062999A2 Proteins and nucleic acids encoding same |
| 08/15/2002 | WO2002062970A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | WO2002062967A2 Multipotent o-2a progenitors from the neurohypophysis |
| 08/15/2002 | WO2002062851A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | WO2002062841A2 Secreted proteins |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062832A2 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | WO2002062830A1 Tripeptide derivatives for the treatment of neurodegenerative diseases |
| 08/15/2002 | WO2002062828A2 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases |
| 08/15/2002 | WO2002062804A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | WO2002062803A1 Thienopyrimidine derivative |
| 08/15/2002 | WO2002062800A1 Bicyclic nitrogenous fused-ring compound |
| 08/15/2002 | WO2002062799A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | WO2002062798A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | WO2002062795A2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof |
| 08/15/2002 | WO2002062792A1 Jnk inhibitor |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062788A1 Sulfonamide compounds, their preparation and use |
| 08/15/2002 | WO2002062784A1 Piperidinee derivatives as neurokinin 1 antagonists |
| 08/15/2002 | WO2002062774A1 Thiazole derivatives for treating ppar related disorders |
| 08/15/2002 | WO2002062767A1 Novel quinazoline derivatives |
| 08/15/2002 | WO2002062762A2 Potassium channel openers |
| 08/15/2002 | WO2002062761A1 Aminal diones as potassium channel openers |
| 08/15/2002 | WO2002062756A1 Aromatic sulfonyl alpha-cycloamino hydroxamates and their use as mmp inhibitors |
| 08/15/2002 | WO2002062751A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/15/2002 | WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 08/15/2002 | WO2002062398A2 Radioactively labelled conjugates of phosphonates |
| 08/15/2002 | WO2002062383A2 Antagonists of myelin-associated glycoprotein and their use in the treatment and/or prevention of neurological diseases |
| 08/15/2002 | WO2002062373A2 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/15/2002 | WO2002062372A2 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/15/2002 | WO2002062366A1 Herbal composition for_the prevention and treatment of dementia |
| 08/15/2002 | WO2002062346A1 Method of treating substance abuse with quetiapine |
| 08/15/2002 | WO2002062343A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS |
| 08/15/2002 | WO2002062332A1 Pharmaceutical composition for treating multiple sclerosis |
| 08/15/2002 | WO2002062327A2 Method of treating neurological disorders using acetone derivatives |
| 08/15/2002 | WO2002062301A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 08/15/2002 | WO2002062299A2 Improved controlled release oral dosage form |
| 08/15/2002 | WO2002062293A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 08/15/2002 | WO2002047685A3 Nmda receptor agonist pharmaceutical compositions |
| 08/15/2002 | WO2002046404A9 Schizophrenia-related voltage-gated ion channel gene and protein |
| 08/15/2002 | WO2002044175A3 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
| 08/15/2002 | WO2002042429A3 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 08/15/2002 | WO2002038035A3 Methods for inhibiting pain |
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses |
| 08/15/2002 | WO2002028866A3 Hydroxyesters of 7-desmethylrapamycin |
| 08/15/2002 | WO2002028434A3 Use of a ppar delta activator for treating inflammatory conditions |
| 08/15/2002 | WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 08/15/2002 | WO2002026729A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/15/2002 | WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 08/15/2002 | WO2002019961A3 Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 08/15/2002 | WO2002018554A3 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 08/15/2002 | WO2002016381B1 Composition and method for inhibiting platelet aggregation |
| 08/15/2002 | WO2002011731A3 Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches |
| 08/15/2002 | WO2002011724A3 Neuroprotective 2-pyridinamine compositions and related methods |
| 08/15/2002 | WO2002003848A3 Method for opening the blood-brain barrier |
| 08/15/2002 | WO2002003815A3 Composition for the treatment of migraine |
| 08/15/2002 | WO2002000195A3 Methods and compositions for treating pain of the mucous membrane |
| 08/15/2002 | WO2001098265A3 Process for isolating enantiomers of racemic cetamine |
| 08/15/2002 | WO2001085995A9 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 08/15/2002 | WO2001028545A9 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 08/15/2002 | WO2001027135A9 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/15/2002 | US20020111490 Certain pyrrolopyridine derivatives: novel CRF1 specific ligands |
| 08/15/2002 | US20020111483 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
| 08/15/2002 | US20020111379 Methods of treating anxiety disorders |
| 08/15/2002 | US20020111374 Estrogen receptor modulators |
| 08/15/2002 | US20020111367 Phenyl substituted pyridine and benzene derivatives |
| 08/15/2002 | US20020111366 Therapy for brain disorders; strokes |
| 08/15/2002 | US20020111358 Phenoxypropylamine compounds |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111350 Aryl fused azapolycyclic compounds |
| 08/15/2002 | US20020111347 Nervous system disorders |
| 08/15/2002 | US20020111343 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-Amyloid peptide release and/or its synthesis by use of such compounds |
| 08/15/2002 | US20020111337 Use of an aldosterone receptor antagonist to improve cognitive function |
| 08/15/2002 | US20020111334 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| 08/15/2002 | US20020111315 Synergistic mixture with antilipemic agent |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020111301 Administering polypeptide mixture |
| 08/15/2002 | US20020111296 Thrombomodulin analogs for use in recovery of spinal cord injury |
| 08/15/2002 | US20020110868 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110608 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |